Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

FDA approves first at-home genetic test to assess breast cancer risk

The kit from the company 23andMe tests for three mutations and is available without a prescription — though the test has limitations and it is recommended that the results are confirmed with a doctor.

Best of NBC News

Play All